Aerie Pharmaceuticals Report issue

Contributed to NME For profit Phase 2 Phase 3 Phase 4
Founded: Bedminster NJ United States (2005)
Status: No NME R&D (2005)

Organization Overview

First Clinical Trial
2007
NCT00523250
First Marketed Drug
2017
netarsudil
First NDA Approval
2017
netarsudil
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Aerie Pharmaceuticals | Aerie Pharmaceuticals Inc. | Aerie Pharmaceuticals, Inc. | Aerie Pharmaceuticals Ireland Ltd. | Aerie Pharmaceuticals Ireland Ltd. (Japan Branch) | AERIE PHARMS INC